FR2413M - New drug, in particular for the treatment of inflammatory and painful manifestations. - Google Patents

New drug, in particular for the treatment of inflammatory and painful manifestations.

Info

Publication number
FR2413M
FR2413M FR916016A FR916016A FR2413M FR 2413 M FR2413 M FR 2413M FR 916016 A FR916016 A FR 916016A FR 916016 A FR916016 A FR 916016A FR 2413 M FR2413 M FR 2413M
Authority
FR
France
Prior art keywords
inflammatory
treatment
new drug
painful manifestations
manifestations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR916016A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR916016A priority Critical patent/FR2413M/en
Application granted granted Critical
Publication of FR2413M publication Critical patent/FR2413M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR916016A 1962-08-20 1962-11-20 New drug, in particular for the treatment of inflammatory and painful manifestations. Active FR2413M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR916016A FR2413M (en) 1962-08-20 1962-11-20 New drug, in particular for the treatment of inflammatory and painful manifestations.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR907282A FR1421229A (en) 1962-08-20 1962-08-20 New quinoline derivative and method of preparation
FR916016A FR2413M (en) 1962-08-20 1962-11-20 New drug, in particular for the treatment of inflammatory and painful manifestations.

Publications (1)

Publication Number Publication Date
FR2413M true FR2413M (en) 1964-03-23

Family

ID=8785397

Family Applications (2)

Application Number Title Priority Date Filing Date
FR907282A Expired FR1421229A (en) 1961-10-17 1962-08-20 New quinoline derivative and method of preparation
FR916016A Active FR2413M (en) 1962-08-20 1962-11-20 New drug, in particular for the treatment of inflammatory and painful manifestations.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR907282A Expired FR1421229A (en) 1961-10-17 1962-08-20 New quinoline derivative and method of preparation

Country Status (2)

Country Link
FR (2) FR1421229A (en)
OA (1) OA01427A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL36521A (en) * 1970-04-15 1974-11-29 Roussel Uclaf M-benzoylphenylacetic acid esters and process of preparation
FR2398719A1 (en) * 1977-07-26 1979-02-23 Fabre Sa Pierre NEW SYNTHESIS INTERMEDIATE: GLYCERYLE ANTHRANILATE AND ITS PREPARATION PROCESS

Also Published As

Publication number Publication date
OA01427A (en) 1969-07-04
FR1421229A (en) 1965-12-17

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR2609M (en) New drug for the treatment of staphylococcal and streptococcal infections.
BE628497A (en) New compound which can be used in particular for the treatment of inflammatory and / or painful manifestations
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR28F (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3187M (en) New drug in particular for the treatment of irregularities and ovarian insufficiencies.
FR3875M (en) New drug particularly suitable for the treatment of tuberculosis infections.
FR2510M (en) New medicament usable for the treatment of staphylococcal infections and the like.
FR1878M (en) New polysaccharide, usable in therapy, in particular for the treatment of solid tumors.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR3881M (en) Medicament useful in particular for the treatment of tuberculosis.
FR1484M (en) New drug in particular for the treatment of inflammatory manifestations of microbial origin.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1412M (en) New drug in particular for the treatment of bronchitis, pneumonia, heart collapse and heart failure.
FR1731M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.